UPMC Enterprises portfolio company, ID Connect, recently received top scores from KLAS Research, reflecting the quality of its services and high customer satisfaction.
In December 2020, ID Connect, which provides telemedicine access to infectious disease specialists and offers an ID-specific clinical decision support tool, was featured in a KLAS Research Spotlight Report. The company earned an exceptional overall score of 96.9 for service, with 80% of its customers who responded reported that they were “highly satisfied” and 20% “satisfied.”
A leader in measuring vendor performance in the health care industry, KLAS bases its scores entirely on customer opinions, ratings and experience.
The ILUM Insight clinical decision support platform had an overall score of 96, with 80% of respondents “highly satisfied” and 20% “satisfied.”
The report showed that organizations see ID Connect as a true partner that helps improve patient safety while also making processes more efficient.
To learn more and download the full report, visit IDCtelemed.com.
